These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30181048)

  • 1. The type of adjuvant in whole inactivated influenza a virus vaccines impacts vaccine-associated enhanced respiratory disease.
    Souza CK; Rajão DS; Sandbulte MR; Lopes S; Lewis NS; Loving CL; Gauger PC; Vincent AL
    Vaccine; 2018 Oct; 36(41):6103-6110. PubMed ID: 30181048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age at Vaccination and Timing of Infection Do Not Alter Vaccine-Associated Enhanced Respiratory Disease in Influenza A Virus-Infected Pigs.
    Souza CK; Rajão DS; Loving CL; Gauger PC; Pérez DR; Vincent AL
    Clin Vaccine Immunol; 2016 Jun; 23(6):470-482. PubMed ID: 27030585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine-Associated Enhanced Respiratory Disease following Influenza Virus Infection in Ferrets Recapitulates the Model in Pigs.
    Kimble JB; Wymore Brand M; Kaplan BS; Gauger P; Coyle EM; Chilcote K; Khurana S; Vincent AL
    J Virol; 2022 Mar; 96(5):e0172521. PubMed ID: 34985999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous prime-boost H1N1 vaccination exacerbates disease following challenge with a mismatched H1N2 influenza virus in the swine model.
    Pliasas VC; Neasham PJ; Naskou MC; Neto R; Strate PG; North JF; Pedroza S; Chastain SD; Padykula I; Tompkins SM; Kyriakis CS
    Front Immunol; 2023; 14():1253626. PubMed ID: 37928521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live attenuated influenza A virus vaccine protects against A(H1N1)pdm09 heterologous challenge without vaccine associated enhanced respiratory disease.
    Gauger PC; Loving CL; Khurana S; Lorusso A; Perez DR; Kehrli ME; Roth JA; Golding H; Vincent AL
    Virology; 2014 Dec; 471-473():93-104. PubMed ID: 25461535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine-associated enhanced respiratory disease is influenced by haemagglutinin and neuraminidase in whole inactivated influenza virus vaccines.
    Rajão DS; Chen H; Perez DR; Sandbulte MR; Gauger PC; Loving CL; Shanks GD; Vincent A
    J Gen Virol; 2016 Jul; 97(7):1489-1499. PubMed ID: 27031847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza A virus hemagglutinin protein subunit vaccine elicits vaccine-associated enhanced respiratory disease in pigs.
    Rajão DS; Loving CL; Gauger PC; Kitikoon P; Vincent AL
    Vaccine; 2014 Sep; 32(40):5170-6. PubMed ID: 25077416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bivalent hemagglutinin and neuraminidase influenza replicon particle vaccines protect pigs against influenza a virus without causing vaccine associated enhanced respiratory disease.
    Wymore Brand M; Anderson TK; Kitikoon P; Brian Kimble J; Otis N; Gauger PC; Souza CK; Kaplan B; Mogler M; Strait E; Vincent Baker AL
    Vaccine; 2022 Sep; 40(38):5569-5578. PubMed ID: 35987871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal vaccination with replication-defective adenovirus type 5 encoding influenza virus hemagglutinin elicits protective immunity to homologous challenge and partial protection to heterologous challenge in pigs.
    Braucher DR; Henningson JN; Loving CL; Vincent AL; Kim E; Steitz J; Gambotto AA; Kehrli ME
    Clin Vaccine Immunol; 2012 Nov; 19(11):1722-9. PubMed ID: 22933397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-fostering to prevent maternal cell transfer did not prevent vaccine-associated enhanced respiratory disease that occurred following heterologous influenza challenge of pigs vaccinated in the presence of maternal immunity.
    Loving CL; Brockmeier SL; Vincent AL; Gauger PC; Zanella EL; Lager KM; Kehrli ME
    Viral Immunol; 2014 Sep; 27(7):334-42. PubMed ID: 24978861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine-associated enhanced respiratory disease does not interfere with the adaptive immune response following challenge with pandemic A/H1N1 2009.
    Gauger PC; Loving CL; Lager KM; Janke BH; Kehrli ME; Roth JA; Vincent AL
    Viral Immunol; 2013 Oct; 26(5):314-21. PubMed ID: 24033080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuraminidase inhibiting antibody responses in pigs differ between influenza A virus N2 lineages and by vaccine type.
    Sandbulte MR; Gauger PC; Kitikoon P; Chen H; Perez DR; Roth JA; Vincent AL
    Vaccine; 2016 Jul; 34(33):3773-9. PubMed ID: 27325350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Adjuvanted-Whole Inactivated Virus and Live-Attenuated Virus Vaccines against Challenge with Contemporary, Antigenically Distinct H3N2 Influenza A Viruses.
    Abente EJ; Rajao DS; Santos J; Kaplan BS; Nicholson TL; Brockmeier SL; Gauger PC; Perez DR; Vincent AL
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30185589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live attenuated influenza vaccine provides superior protection from heterologous infection in pigs with maternal antibodies without inducing vaccine-associated enhanced respiratory disease.
    Vincent AL; Ma W; Lager KM; Richt JA; Janke BH; Sandbulte MR; Gauger PC; Loving CL; Webby RJ; García-Sastre A
    J Virol; 2012 Oct; 86(19):10597-605. PubMed ID: 22811541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs.
    Dhakal S; Renu S; Ghimire S; Shaan Lakshmanappa Y; Hogshead BT; Feliciano-Ruiz N; Lu F; HogenEsch H; Krakowka S; Lee CW; Renukaradhya GJ
    Front Immunol; 2018; 9():934. PubMed ID: 29770135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterologous challenge in the presence of maternally-derived antibodies results in vaccine-associated enhanced respiratory disease in weaned piglets.
    Rajao DS; Sandbulte MR; Gauger PC; Kitikoon P; Platt R; Roth JA; Perez DR; Loving CL; Vincent AL
    Virology; 2016 Apr; 491():79-88. PubMed ID: 26874588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers associated with vaccine-associated enhanced respiratory disease following influenza A virus infection in swine.
    Wymore Brand M; Souza CK; Gauger P; Arruda B; Vincent Baker AL
    Vet Immunol Immunopathol; 2024 Jul; 273():110787. PubMed ID: 38815504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quadrivalent neuraminidase RNA particle vaccine protects pigs against homologous and heterologous strains of swine influenza virus infection.
    Kitikoon P; Knetter SM; Mogler MA; Morgan CL; Hoehn A; Puttamreddy S; Strait EL; Segers RPAM
    Vaccine; 2023 Nov; 41(47):6941-6951. PubMed ID: 37884412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease.
    Khurana S; Loving CL; Manischewitz J; King LR; Gauger PC; Henningson J; Vincent AL; Golding H
    Sci Transl Med; 2013 Aug; 5(200):200ra114. PubMed ID: 23986398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza A Virus in Swine: Epidemiology, Challenges and Vaccination Strategies.
    Mancera Gracia JC; Pearce DS; Masic A; Balasch M
    Front Vet Sci; 2020; 7():647. PubMed ID: 33195504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.